NCT03126149View on ClinicalTrials.gov

First in Human Study for PF-06667272

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

September 5, 2017

Study Completion Date

September 5, 2017

Conditions

Healthy

Interventions

DRUG

PF-06667272

Single ascending dose of PF-06667272

OTHER

Placebo

Single dose of placebo

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY